SCHEMBL2424482

SCHEMBL2424482

C[C@@H](Oc1c(N)ncc2c(-c3cnn(C4CCNCC4)c3)coc12)c1c(Cl)c(F)cc(F)c1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 1.00
MST1R Q04912 3/20 0.85
CYP3A4 P08684 1/20 0.68
ALK Q9UM73 3/20 0.56
MAP4K3 Q8IVH8 2/20 0.56
PLK4 O00444 2/20 0.56
AURKA O14965 2/20 0.56
DCLK1 O15075 2/20 0.56
JAK2 O60674 2/20 0.56
PRKD3 O94806 2/20 0.56
ABL1 P00519 2/20 0.56
NTRK1 P04629 2/20 0.56
INSR P06213 2/20 0.56
LCK P06239 2/20 0.56
FES P07332 2/20 0.56
CSF1R P07333 2/20 0.56
LYN P07948 2/20 0.56
RET P07949 2/20 0.56
IGF1R P08069 2/20 0.56
ROS1 P08922 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2420736 1.00 MET (1.00) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2423846 0.93 MET (0.91) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2423926 0.93 MET (0.91) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2428483 0.93 MET (0.86) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2426856 0.92 MET (1.00) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2429915 0.92 MET (1.00) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2428419 0.92 MET (1.00) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2423678 0.92 MET (0.84) METMST1RCYP3A4ALKMAP4K3
SCHEMBL2427744 0.92 MET (0.84) METMST1RCYP3A4ALKMAP4K3
Hydrochloric Acid SCHEMBL2422062 0.91 MET (0.99) METMST1RCYP3A4ALKMAP4K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265616-B1 FURO-AND THIENO[3,2-C]PYRIDINES OSI PHARM INC (US) 2013-11-20 EP claimed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US claimed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US claimed
EP-2265616-B1 FURO-AND THIENO[3,2-C]PYRIDINES OSI PHARM INC (US) 2013-11-20 EP disclosed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US disclosed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines RET, MET, ERBB2 MET 2/4885MST1R 104/4885CYP3A4 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.